News
Catalent Completes Purchase of Teva Takeda Packaging Facility
Catalent, a global leader in clinical supply services, announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the Shiga prefecture of Japan.
Operating in partnership with the company’s existing Japanese clinical supply facility...
News
IBM Watson Health selects iBio to support COVID-19 vaccine candidates
IBM Watson Health selected iBio to receive 18 months use of the IBM clinical development (ICD) solution at no cost.
IBM Watson Health recently began offering its clinical development solution to eligible trial sponsor organizations as part of its efforts...
News
ACG Films & Foils strengthens its presence in South America
ACG Films & Foils, part of the ACG Group, the only supplier in the world offering end-to-end manufacturing solutions for the pharmaceutical and nutraceutical industry, has further strengthened its global position by adding a coating line to the existing...
News
Symbiosis secures £1 million of growth finance from Allied Irish Bank (GB)
Symbiosis Pharmaceutical Services has secured £1million of finance from Allied Irish Bank (GB) to support its 2020 growth strategy.
Symbiosis provides niche, sterile manufacturing services to global biotechnology and pharmaceutical company clients that are developing novel drug therapies and vaccines...
News
Softbox introduces eco-packaging solution for the pharma cold chain industry
Softbox, a leading global innovator and provider of temperature control packaging solutions for the pharmaceutical, life science and cold chain logistic industries announced the launch of Tempcell™ ECO, a new curbside-recyclable temperature control parcel shipper.
Tempcell™ ECO is made from...
News
Announcing New QuickSTAT Podcast – Life Science Logistics in a Life-changing World
The Quick Group has just launched another episode of their QuickConversations podcast, designed to help the life science and medical research community keep their global clinical trials moving during the pandemic – utilizing best practices and proven patient-centric solutions.
The...
News
Avalon GloboCare Achieves Milestones in Advancing Novel Intranasal and Oral COVID-19 Vaccine Candidate
Avalon GloboCare Corp., a clinical-stage global developer of cell-based technologies and therapeutics, announced a strategic partnership with the University of Natural Resources and Life Sciences (BOKU) in Vienna, Austria to develop an S-layer vaccine that can be administered by...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read